Eli Lilly and Company News Releases

Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies

Agreement will significantly increase global supply capacity for Lilly's potential COVID-19 treatments INDIANAPOLIS and THOUSAND OAKS, Calif. , Sept. 17, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Amgen (NASDAQ:AMGN) today announced a global antibody manufacturing collaboration to
favicon
investor.lilly.com
investor.lilly.com